发明授权
US07803411B2 Physiologically active substance NK13650P3, method of producing the same and use thereof
失效
生理活性物质NK13650P3,其生产方法及其应用
- 专利标题: Physiologically active substance NK13650P3, method of producing the same and use thereof
- 专利标题(中): 生理活性物质NK13650P3,其生产方法及其应用
-
申请号: US11922266申请日: 2006-06-26
-
公开(公告)号: US07803411B2公开(公告)日: 2010-09-28
- 发明人: Arihiro Tomura , Junko Odanaka , Masakazu Nishimoto
- 申请人: Arihiro Tomura , Junko Odanaka , Masakazu Nishimoto
- 申请人地址: JP Tokyo
- 专利权人: Nippon Kayaku Kabushiki Kaisha
- 当前专利权人: Nippon Kayaku Kabushiki Kaisha
- 当前专利权人地址: JP Tokyo
- 代理机构: Nields, Lemack & Frame, LLC
- 优先权: JP2005-186182 20050627
- 国际申请: PCT/JP2006/312726 WO 20060626
- 国际公布: WO2007/000978 WO 20070104
- 主分类号: A61K35/00
- IPC分类号: A61K35/00 ; A01N65/04 ; C12P1/02
摘要:
A physiologically active substance NK13650P3 having the following physicochemical properties or a pharmacologically acceptable salt thereof. 1) Appearance: pale yellow powder 2) Molecular formula: C29H37N7O15 3) Molecular weight: 723 4) Hydrogen nuclear magnetic resonance spectrum: spectrum measured at 600 MHz in heavy water contains the following signals: chemical shift value δ ppm: 7.05 (1H, 3), 7.00 (1H, d), 6.96 (1H, d), 6.83 (1H, s), etc. 5) Carbon nuclear magnetic resonance spectrum: spectrum measured at 150 MHz in heavy water contains the following signals: chemical shift value δ ppm: 181.5(s), 181.4(s), 179.9(s), 179.2(s), 174.5(s), 174.3(s), 171.5(s), 165.4(s), etc. 6) Ultraviolet light spectrum: spectrum measured in aqueous solution contains the following UV absorption bands: λmax (MeOH): 196.5 nm, 224.5 nm, 322.5 nm 7) Solubility: highly soluble in water but insoluble in methanol, acetone, ethyl acetate, chloroform and dimethyl sulfoxide. 8) Coloration reaction: positive to phosphomolybdic acid/sulfuric acid reaction and Rydon-Smith reaction.
公开/授权文献
信息查询